View in EDS HTML Full Text PDF Full Text

Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis.

Saved in:
Bibliographic Details
Title: Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis.
Authors: Sánta, Hermina1 (AUTHOR), Regáli, Laura2 (AUTHOR), Váróczy, László3 (AUTHOR), Szita, Virág4 (AUTHOR), Wiedemann, Ádám4,5 (AUTHOR), Varju, Lóránt5,6 (AUTHOR), Rejtő, László5,7 (AUTHOR), Bartha, Norbert Sándor5,8 (AUTHOR), Máté, Dorottya6,9 (AUTHOR), Masszi, András6,10 (AUTHOR), Plander, Márk1,7 (AUTHOR), Kosztolányi, Szabolcs2,8 (AUTHOR), Hussain, Alizadeh3,8 (AUTHOR), Pettendi, Piroska4,9 (AUTHOR), Istenes, Ildikó5,10 (AUTHOR), Szomor, Árpád1,6 (AUTHOR), Reményi, Péter2,7 (AUTHOR), Masszi, Tamás4,8 (AUTHOR), Varga, Gergely4,9 (AUTHOR), Mikala, Gábor4,10 (AUTHOR) mikala.gabor@semmelweis.hu
Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p286. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm15010286